{ "docId": "019dd923-622c-750b-8b9a-1a3bea94baf9", "docSlug": "c358888161f0", "documentTitle": "Ginkgo Bioworks (DNA)", "authorId": "58_Scorpion_Capital", "authorName": "Scorpion Capital", "documentKindSlug": "activist-deck", "documentKindLabel": "Activist deck", "sourceTypeSlug": "short_seller", "sourceTypeLabel": "Short seller", "presentationDate": "2021-10-06 00:00:00", "orientation": "landscape", "aspectRatio": 1.2941177, "pageNumber": 173, "pageCount": 175, "prevPage": 172, "nextPage": 174, "slideType": "quote_slide", "function": "expose_contradiction", "density": "dense", "nDataPoints": 0, "notes": "The slide uses expert testimony to argue that the two companies are undifferentiated and that Ginkgo's projects are higher risk.", "elementsJson": [ "paragraph", "quote_block", "footnote" ], "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019dd923-622c-750b-8b9a-1a3bea94baf9/173", "deckHref": "/decks/019dd923-622c-750b-8b9a-1a3bea94baf9", "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-1a3bea94baf9.json", "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-1a3bea94baf9#slide-173", "components": [ { "bbox": null, "kind": "callout", "text": "Ginkgo and Zymergen “were always looking jealously as each other”; not much differentiation between the two; “more similar to each other than they are different”", "attrs": null, "subkind": null, "toolName": "Visual emphasis", "toolSlug": "visual-emphasis", "confidence": null, "componentId": "019dd953-2b63-72e1-b602-0fdb2ae6c171", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.15, "w": 0.9, "x": 0.05, "y": 0.08 }, "kind": "paragraph", "text": "A former director-level employee of Ginkgo re-iterated comments by his colleagues, stating that Zymergen and Ginkgo are very similar, and that if anything Zymergen’s science was lower-risk. He indicated that both companies “were always looking jealously at each other”; that there’s little differentiation between the two; and that they’re “more similar to each other than they are different.”", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "50fdb6d7-df49-4fb9-b49c-a39aec1dfd25", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.12, "w": 0.9, "x": 0.05, "y": 0.8 }, "kind": "quote", "text": "I think both companies were always looking jealously at each other or trying to one-up each other. But I don't think there's a large differentiation between the two companies per se besides that historical philosophy.", "attrs": null, "subkind": "testimonial", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "02e9afbb-2703-43c9-bb68-5811c3821eb0", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.12, "w": 0.9, "x": 0.05, "y": 0.6 }, "kind": "quote", "text": "Ginkgo has always been more of the let's not do strain improvement per se, but let's actually build novel products or start from scratch... Ginkgo was always a higher risk but more sexy projects. Zymergen was just kind of ho-hum.", "attrs": null, "subkind": "testimonial", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "60366065-2f04-42d3-935c-4981de33a1fa", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.1, "w": 0.9, "x": 0.05, "y": 0.36 }, "kind": "quote", "text": "I mean, they had very similar beginnings, Zymergen and Ginkgo. What was different about the two companies, really, and this maybe seems like I'm splitting hairs a little bit, but Zymergen was always focused on lower-risk science.", "attrs": null, "subkind": "testimonial", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "bfaf5978-e6f1-4b20-b069-100e03e7e041", "frameworkName": null, "frameworkSlug": null }, { "bbox": null, "kind": "quote", "text": "“I mean, they had very similar beginnings, Zymergen and Ginkgo. What was different about the two companies, really, and this maybe seems like I'm splitting hairs a little bit, but Zymergen was always focused on lower-risk science.” — Former Ginkgo director level employee; “Ginkgo has always been more of the let's not do strain improvement per se, but let's actually build novel products or start from scratch... Ginkgo was always a higher risk but more sexy projects. Zymergen was just kind of ho-hum.” — Former Ginkgo director level employee; “I think both companies were always looking jealously at each other or trying to one-up each other. But I don't think there's a large differentiation between the two companies per se besides that historical philosophy... they're more similar to each other than they are different.” — Former Ginkgo director level employee", "attrs": null, "subkind": null, "toolName": "Authority citation", "toolSlug": "authority-citation", "confidence": null, "componentId": "019dd953-2b63-72e1-b602-1302ad26c6a7", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.02, "w": 0.3, "x": 0.05, "y": 0.96 }, "kind": "source-note", "text": "Source: Scorpion Capital consultation calls with experts", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "ac6e3a46-5e04-45c4-800b-a5f3a1df2956", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [ { "name": "authority-citation", "slug": null, "matchId": "8ed33337-1951-4f23-80f1-1b99f78d4f4b", "evidence": "Uses expert testimony to validate the thesis of similarity and risk.", "confidence": 0.9 } ], "arcBeats": [ { "to": 175, "from": 9, "beatId": "ffe290af-3a4f-4e06-8d60-dfbfc07d2e08", "arcName": "Overcoming the Monster", "arcSlug": "overcoming-monster", "beatName": "Expose Contradiction", "beatSlug": null, "evidence": "The deck presents evidence contradicting Ginkgo's claims and highlighting potential wrongdoings.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "loops": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }